top of page

Pavaka Wound Care Files Two U.S. Provisional Patent Applications Covering Next-Generation Dressing Designs

Writer: Brent Toto
Brent Toto
Jun 25
2 min read

Updated: 7 days ago

COLUMBUS, Ohio — June 25, 2026 — Pavaka Wound Care has filed two U.S. provisional patent applications covering next-generation electroceutical dressing designs. They expand the company's intellectual property beyond the platform it exclusively licenses from The Ohio State University.


The applications were filed with the U.S. Patent and Trademark Office through Pavaka's patent counsel, Thompson Hine LLP. They cover innovations that came out of Pavaka's own product development work.


A provisional application establishes an early filing date for an invention while the company keeps refining it. Within 12 months, Pavaka can file corresponding non-provisional applications, which the USPTO will then examine.


These filings add a new layer to Pavaka's IP position. The company exclusively licenses Ohio State's issued U.S. Patent No. 12,102,508, "Antimicrobial Wound Care Dressing," along with related Ohio State applications. Owning patent filings on its own innovations alongside the licensed foundation lets Pavaka protect improvements as the product evolves from research prototype to manufacturable device.


New patent filings were one of the priorities supported by the Concept Contract award Pavaka received from Rev1 Ventures in late 2025, alongside development of next-generation dressing designs.


Pavaka's investigational dressing generates a low-level electric field at the wound surface. The company is developing it for chronic and acute wounds, including those complicated by multidrug-resistant bacteria and biofilms, and is working toward the appropriate U.S. Food and Drug Administration pathway.


Pavaka will continue to build its portfolio as development progresses, working with Ohio State on the licensed estate and with its own counsel on company-owned inventions.


The USPTO does not publish provisional applications, so details of the inventions will stay confidential until later filings become public.


Building a company-owned patent position is especially important for a platform technology. It protects how Pavaka makes the dressing easier to manufacture and use, and it supports future partnerships.


"Our job is to keep improving on a great foundation. These filings protect the innovations our team has developed and make sure Pavaka owns the next generation of this technology." — Frank Fischer, Chief Technology Officer and Co-Founder

Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.


About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Sources and further reading

Comments


bottom of page